Silver Creek Pharmaceuticals is a biotechnology company, develops protein therapeutics to treat cardiovascular diseases.
Silver Creek Pharmaceuticals has raised $9.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2022.
Silver Creek Pharmaceuticals's investors include Goldman Sachs, JP Morgan, Absa Bank Kenya.
Silver Creek Pharmaceuticals is headquartered in San Francisco, United States.
Silver Creek Pharmaceuticals is a biotechnology company, develops protein therapeutics to treat cardiovascular diseases.
Silver Creek Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Silver Creek Pharmaceuticals — Funding & Investors." VCBacked, February 11, 2022, https://www.vcbacked.co/company/silver-creek-pharmaceuticals. Accessed July 20, 2026.
VCBacked. (2022). Silver Creek Pharmaceuticals — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/silver-creek-pharmaceuticals
{{cite web |title=Silver Creek Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/silver-creek-pharmaceuticals |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated